Robert Benjamin Stein - 25 Mar 2024 Form 4 Insider Report for Protagenic Therapeutics, Inc.\new (PTIX)

Role
Director
Signature
/s/ William F. Hulse as attorney in fact for Robert Benjamin Stein
Issuer symbol
PTIX
Transactions as of
25 Mar 2024
Net transactions value
+$130,500
Form type
4
Filing time
29 Mar 2024, 21:29:23 UTC
Previous filing
17 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTIX PTIX Common stock Options Award $130,500 +75,000 $1.74 75,000 25 Mar 2024 PTIX Common Stock, Par Value $0.0001 75,000 $1.74 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 50,000 of the options are fully-exerciseable on March 25, 2026. The other 25,000 of the options are exercisable on and after the date upon which the company consummates a corporate partnership, if that occurs before December 31, 2026. If the company does not enter into a corporate partnership before December 31, 2026, then those 25,000 options are never exercisable.